Angiolutions Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2.76M

  • Investors
  • 9

Angiolutions General Information

Description

Developer of therapeutic devices designed for the treatment of vascular diseases. The company specializes in developing a novel vascular graft that prevents small abdominal aortic aneurysm growth, enabling healthcare professionals to assist patients in preventing and curing vascular diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Vahrenwalder Straße 269A
  • 30179 Hannover
  • Germany
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Vahrenwalder Straße 269A
  • 30179 Hannover
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Angiolutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 27-Jul-2023 $2.76M Completed Generating Revenue
4. Seed Round 01-Feb-2021 Completed Generating Revenue
3. Accelerator/Incubator 01-Aug-2018 Completed Startup
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Angiolutions’s complete valuation and funding history, request access »

Angiolutions Patents

Angiolutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102023131688-A1 Stent for the treatment of an abdominal aortic aneurysm Pending 14-Nov-2023
AU-2024380229-A1 Stent for treating an abdominal aortic aneurysm Pending 14-Nov-2023
EP-4808484-A1 Stent for treating an abdominal aortic aneurysm Pending 14-Nov-2023
WO-2025104011-A1 Stent for treating an abdominal aortic aneurysm Inactive 14-Nov-2023
AU-2023382512-A1 Self-expandable stent Pending 15-Nov-2022 A61F2/915
To view Angiolutions’s complete patent history, request access »

Angiolutions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Angiolutions Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
European Innovation Council Accelerator/Incubator Minority
Beteiligungsgesellschaft Stadt Solingen Corporation Minority
FRIBA Investment Family Office Minority
High-Tech Gründerfonds Venture Capital Minority
NBank Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Angiolutions FAQs

  • When was Angiolutions founded?

    Angiolutions was founded in 2017.

  • Where is Angiolutions headquartered?

    Angiolutions is headquartered in Hannover, Germany.

  • What is the size of Angiolutions?

    Angiolutions has 9 total employees.

  • What industry is Angiolutions in?

    Angiolutions’s primary industry is Therapeutic Devices.

  • Is Angiolutions a private or public company?

    Angiolutions is a Private company.

  • What is Angiolutions’s current revenue?

    The current revenue for Angiolutions is .

  • How much funding has Angiolutions raised over time?

    Angiolutions has raised $2.25M.

  • Who are Angiolutions’s investors?

    European Innovation Council, Beteiligungsgesellschaft Stadt Solingen, FRIBA Investment, High-Tech Gründerfonds, and NBank Capital are 5 of 9 investors who have invested in Angiolutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process